TORONTO, Canada – July 2, 2013 – Cyclica Inc. has been awarded access to IBM’s Blue Gene supercomputer to optimize drug discovery and development using existing drugs that have been… Continue reading Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs
Sherbrooke International Life Sciences Summit (SILS), September 26th & 27th 2013. A unique chance to develop business partnerships with large pharmaceutical and medical technologies businesses! Register now! Regular Rate | Early Bird:… Continue reading Sherbrooke International Life Sciences Summit
Funded by the Government of Canada, Grand Challenges Canada is dedicated to supporting bold ideas with big impact in global health. The Challenge Massive inequalities in health exist across the… Continue reading Grand Challenges Canada: Vote for ViroCarb’s Life-Saving Medicine against HIV
By: Richard Y. Cheung and Ingrid VanderElst | Toronto On January 18, 2013, the Canadian provinces and territories (with the exception of Quebec) announced a joint initiative (PDF) designed to… Continue reading First Step to Pan-Canadian Approach to Management of Drug Costs
By Jeremy Grushcow Use of social media by pharmaceutical companies, biotechs, and industry observers will continue to grow in scale, value and importance this year. The emergence of Twitter as… Continue reading Social Media in Biotech and Healthcare
© 2026 Altitude Accelerator | Brampton, Ontario, Canada
